Literature DB >> 8819830

Nocardia brasiliensis: in vitro and in vivo growth response to steroid sex hormones.

F Hernandez-Hernandez1, R Lopez-Martinez, L J Mendez-Tovar, P Manzano-Gayosso.   

Abstract

As actinomycetoma is more frequent in males than in females, the possibility that hormones might modify the Nocardia brasiliensis growth and the course of experimental actinomycetoma was explored. Five N. brasiliensis strains were grown on Sabouraud agar containing estradiol, progesterone or testosterone, in 3 different concentrations. Colony diameters were measured weekly for 7 weeks. N. brasiliensis strains were also grown in Sabouraud broth containing hormones. Glucose concentration was measured weekly for 6 weeks. Finally, experimental actinomycetoma was produced in male and female hormone-treated mice. Invasion rate, plantar pad diameter and positive retrocultures were assessed. In vitro experiments showed that progesterone and testosterone inhibit N. brasiliensis growth, manifested by lower colony diameters and greater glucose concentrations. In vivo experiments demonstrated that estradiol limits actinomycetoma development. Progesterone and testosterone induced greater diameters of inoculated plantar pads and greater invasion rates with greater positive culture numbers than estradiol. Results partially explain the resistance of females to actinomycetoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8819830     DOI: 10.1007/bf01103779

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  19 in total

1.  Mycetoma by Nocardia brasiliensis. Isolation of the agent from soils.

Authors:  A GONZALEZ-OCHOA
Journal:  Rev Inst Salubr Enferm Trop       Date:  1962-06

2.  Circulating concentrations of FSH, LH, estradiol, and progesterone associated with acute, male-induced puberty in female mice.

Authors:  F H Bronson; C Desjardins
Journal:  Endocrinology       Date:  1974-06       Impact factor: 4.736

3.  A corticosteroid binding protein and endogenous ligand in C. albicans indicating a possible steroid-receptor system.

Authors:  D S Loose; D J Schurman; D Feldman
Journal:  Nature       Date:  1981-10-08       Impact factor: 49.962

4.  Paracoccidioidomycosis, (South American blastomycosis). A study of 39 cases observed in Medellin, Colombia.

Authors:  A Restrepo; M Robledo; F Gutiérrez; M Sanclemente; E Castañeda; G Calle
Journal:  Am J Trop Med Hyg       Date:  1970-01       Impact factor: 2.345

5.  Dermatophyte-hormone relationships: characterization of progesterone-binding specificity and growth inhibition in the genera Trichophyton and Microsporum.

Authors:  K V Clemons; G Schär; E P Stover; D Feldman; D A Stevens
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

6.  Estradiol binds to a receptor-like cytosol binding protein and initiates a biological response in Paracoccidioides brasiliensis.

Authors:  D S Loose; E P Stover; A Restrepo; D A Stevens; D Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

7.  Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis.

Authors:  A Restrepo; M E Salazar; L E Cano; E P Stover; D Feldman; D A Stevens
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  [Epidemiology of mycetoma in Mexico: study of 2105 cases].

Authors:  R López Martínez; L J Méndez Tovar; P Lavalle; O Welsh; A Saúl; E Macotela Ruíz
Journal:  Gac Med Mex       Date:  1992 Jul-Aug       Impact factor: 0.302

9.  The effect of selected human steroid hormones upon the growth of dermatophytes with different adaptation to man.

Authors:  J Brasch; D Gottkehaskamp
Journal:  Mycopathologia       Date:  1992-11       Impact factor: 2.574

10.  Progesterone binding and inhibition of growth in Trichophyton mentagrophytes.

Authors:  G Schär; E P Stover; K V Clemons; D Feldman; D A Stevens
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

View more
  8 in total

1.  Actinomycetoma in arm disseminated to lung with grains of Nocardia brasiliensis with peripheral filaments.

Authors:  Bertha Muñoz-Hernández; María Cecilia Noyola; Gabriel Palma-Cortés; Dora Patricia Rosete; Miguel Angel Galván; María Eugenia Manjarrez
Journal:  Mycopathologia       Date:  2009-02-24       Impact factor: 2.574

2.  Mycetoma: experience of 482 cases in a single center in Mexico.

Authors:  Alexandro Bonifaz; Andrés Tirado-Sánchez; Luz Calderón; Amado Saúl; Javier Araiza; Marco Hernández; Gloria M González; Rosa María Ponce
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

Review 3.  Mycetoma: An Update.

Authors:  Vineet Relhan; Khushbu Mahajan; Pooja Agarwal; Vijay Kumar Garg
Journal:  Indian J Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.494

4.  Nocardiosis at an Organ Transplant Center in Saudi Arabia: 15 years' experience.

Authors:  Ihab Weheba; Abeer Abdelsayed; Abdulrahman A Alrajhi; Sahar I Al-Thawadi; Abdullah Mobeireek
Journal:  J Glob Infect Dis       Date:  2021-01-29

5.  MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China.

Authors:  Ming Wei; Xinmin Xu; Jingxian Yang; Peng Wang; Yongzhe Liu; Shuai Wang; Chunxia Yang; Li Gu
Journal:  BMC Microbiol       Date:  2021-12-13       Impact factor: 3.605

6.  Estradiol Aggravate Nocardia farcinica Infections in Mice.

Authors:  Lichao Han; Xingzhao Ji; Xueping Liu; Shuai Xu; Fang Li; Yanlin Che; Xiaotong Qiu; Lina Sun; Zhenjun Li
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

Review 7.  Clinical Features of Mycetoma and the Appropriate Treatment Options.

Authors:  Pooja Agarwal; Ashish Jagati; Santoshdev P Rathod; Kirti Kalra; Shefali Patel; Malay Chaudhari
Journal:  Res Rep Trop Med       Date:  2021-07-08

Review 8.  Isolated Nocardiosis, an Unrecognized Primary Immunodeficiency?

Authors:  Rubén Martínez-Barricarte
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.